Free RSV Vaccine Rollout Targets Older Australians Ahead of Winter
A significant public health expansion is now rolling out across Australia, aimed at protecting some of the country’s most vulnerable people as the winter respiratory season approaches.
Respiratory syncytial virus, or RSV, is at the center of this move. While many people experience RSV as a common winter illness similar to flu, it can become far more serious in older adults and infants. In severe cases, it can lead to pneumonia, breathing difficulties, hospitalisation and even death. Health data from Australia shows hundreds of RSV-related deaths recorded in recent years, highlighting that this is far from a mild seasonal virus for everyone.
From May 15, a free RSV vaccination program will be available nationwide. It targets Australians aged 75 and over, as well as Aboriginal and Torres Strait Islander people aged 60 and above. The vaccine, known as Arexvy, is generally given as a single dose and would otherwise cost around 300 dollars on the private market.
Also Read:- Spurs vs Trail Blazers Clash Sparks Momentum Shift in Tight NBA Battle
- Gibbs-White Hat-Trick Fires Forest Past Burnley as Relegation Looms
Health officials say this rollout comes at a critical time, just ahead of peak winter transmission. RSV spreads easily through respiratory droplets and contaminated surfaces and people can pass it on even before symptoms fully develop. That makes it especially concerning in settings like aged care facilities and within families where older adults often help care for young children.
Clinical evidence suggests the vaccine can reduce symptomatic RSV illness by more than 80 percent in the first season after vaccination and it also lowers the risk of severe outcomes like hospitalisation. While protection is expected to last for a few years, booster doses are not currently recommended.
Like all vaccines, there are side effects, most commonly mild fatigue, headache, or soreness at the injection site. Rare neurological complications have been reported, but health experts stress that RSV infection itself can also carry similar risks.
Authorities are also encouraging eligible people to receive the flu vaccine at the same time, strengthening protection ahead of winter. With RSV already placing pressure on hospitals in previous seasons, officials say this program is designed to reduce avoidable illness, ease healthcare demand and protect older Australians during their most vulnerable months.
As winter approaches, this rollout marks a major shift in preventive care strategy. Staying informed and acting early could make a critical difference in reducing serious respiratory illness across communities.
Read More:
0 Comments